A Framework for Estimating Restricted Mean Survival Time Difference using Pseudo-observations
By: Man Jin, Yixin Fang
Potential Business Impact:
Finds best medicine by comparing patient survival.
A targeted learning (TL) framework is developed to estimate the difference in the restricted mean survival time (RMST) for a clinical trial with time-to-event outcomes. The approach starts by defining the target estimand as the RMST difference between investigational and control treatments. Next, an efficient estimation method is introduced: a targeted minimum loss estimator (TMLE) utilizing pseudo-observations. Moreover, a version of the copy reference (CR) approach is developed to perform a sensitivity analysis for right-censoring. The proposed TL framework is demonstrated using a real data application.
Similar Papers
Bayesian analysis of restricted mean survival time adjusted for covariates using pseudo-observations
Applications
Helps doctors compare treatments more accurately.
Treatment Effect Estimation in Causal Survival Analysis: Practical Recommendations
Methodology
Helps doctors choose best treatments for patients.
Beyond Fixed Restriction Time: Adaptive Restricted Mean Survival Time Methods in Clinical Trials
Methodology
Finds hidden treatment benefits in patient data.